LGALS3BP and neuroblastoma: This ADC demonstrated efficacy in SKNAS subcutaneous NB xenografts, orthotopic SH-SY5Y-LUC adrenal xenografts, and patient-derived stage 4 NB xenografts (COG-N-636 and COG-N-603) with high LGALS3BP expression.